Certified by Founder Lodge
Genesis Therapeutics
United States - Burlingame, California
START UP
1 Disclosed Funding Rounds $200,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Genesis Therapeutics – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego – is unifying AI and biotechnology to discover novel and breakthrough treatments for pa
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 22 ,2023 | Series B | $200,000,000 |
Radical Ventures
Menlo Ventures
BlackRock
T. Rowe Price
Rock Springs Capital
a16z Bio + Health
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
